S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: World shares mostly lower as Congress averts a US government shutdown
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: World shares mostly lower as Congress averts a US government shutdown
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: World shares mostly lower as Congress averts a US government shutdown
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: World shares mostly lower as Congress averts a US government shutdown
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
NASDAQ:ICPT

Intercept Pharmaceuticals (ICPT) News Today

$18.54
-0.03 (-0.16%)
(As of 09/29/2023 08:53 PM ET)
Compare
Today's Range
$18.51
$18.61
50-Day Range
$9.99
$18.71
52-Week Range
$8.82
$21.86
Volume
3.89 million shs
Average Volume
1.27 million shs
Market Capitalization
$774.60 million
P/E Ratio
2.90
Dividend Yield
N/A
Price Target
$23.18
SourceHeadline
MarketBeat logoIntercept Pharmaceuticals (NASDAQ:ICPT) Given "Hold" Rating at Canaccord Genuity Group
americanbankingnews.com - September 30 at 5:15 AM
MarketBeat logoHC Wainwright Downgrades Intercept Pharmaceuticals (NASDAQ:ICPT) to Neutral
americanbankingnews.com - September 29 at 4:41 AM
MarketBeat logoB. Riley Comments on Intercept Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ICPT)
americanbankingnews.com - September 29 at 2:21 AM
msn.com logoIntercept Pharma unlikely to see rival offers, other roadblocks, analysts say
msn.com - September 28 at 10:48 PM
msn.com logoCanaccord Genuity Downgrades Intercept Pharmaceuticals (ICPT)
msn.com - September 28 at 10:48 PM
MarketBeat logoIntercept Pharmaceuticals (NASDAQ:ICPT) PT Raised to $19.00 at Royal Bank of Canada
americanbankingnews.com - September 28 at 4:23 AM
MarketBeat logoIntercept Pharmaceuticals (NASDAQ:ICPT) Sees Strong Trading Volume After Analyst Upgrade
americanbankingnews.com - September 28 at 1:32 AM
marketbeat.com logoRoyal Bank of Canada Increases Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target to $19.00
marketbeat.com - September 27 at 9:40 AM
markets.businessinsider.com logoIntercept Pharma Acquisition by Alfasigma: A Strategic Move and Fair Value Assessment
markets.businessinsider.com - September 27 at 5:01 AM
proactiveinvestors.com logoIntercept Pharmaceuticals stock soars on Alfasigma acquisition deal
proactiveinvestors.com - September 27 at 5:01 AM
MarketBeat logoIntercept Pharmaceuticals (NASDAQ:ICPT) Downgraded by B. Riley to "Neutral"
americanbankingnews.com - September 27 at 3:52 AM
msn.com logoCanaccord cuts Intercept to hold, calls Alfasigma deal "best possible outcome"
msn.com - September 26 at 9:08 PM
benzinga.com logoShareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma
benzinga.com - September 26 at 4:07 PM
seekingalpha.com logoIntercept Pharmaceuticals: Alfasigma Pays Premium For M&A Deal That Suits All Parties
seekingalpha.com - September 26 at 3:35 PM
investorplace.com logoWhy Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
investorplace.com - September 26 at 3:10 PM
marketwatch.com logoIntercept Pharma Shares Surge Toward Alfasigma Acquisition Price
marketwatch.com - September 26 at 11:07 AM
msn.com logoIntercept Pharmaceuticals’ stock set to soar after Alfasigma buyout deal for an 82% premium
msn.com - September 26 at 11:07 AM
reuters.com logoItaly's Alfasigma to buy drugmaker Intercept for nearly $800 mln
reuters.com - September 26 at 11:07 AM
markets.businessinsider.com logoAlfasigma To Acquire Intercept Pharma Fo $19 Per Share In Cash
markets.businessinsider.com - September 26 at 11:07 AM
markets.businessinsider.com logoWhy Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?
markets.businessinsider.com - September 26 at 11:07 AM
finance.yahoo.com logoAlfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
finance.yahoo.com - September 26 at 11:07 AM
finance.yahoo.com logoUPDATE 2-Italy's Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mln
finance.yahoo.com - September 26 at 11:07 AM
marketbeat.com logo
marketbeat.com - September 26 at 7:59 AM
MarketBeat logoZacks Research Weighs in on Intercept Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:ICPT)
americanbankingnews.com - September 22 at 2:20 AM
marketbeat.com logoFY2025 EPS Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Lifted by Zacks Research
marketbeat.com - September 20 at 6:38 AM
markets.businessinsider.com logoIntercept Pharma (ICPT) Receives a Hold from RBC Capital
markets.businessinsider.com - September 9 at 12:09 AM
finance.yahoo.com logoWhy CymaBay Therapeutics Stock Is Jumping Today
finance.yahoo.com - September 8 at 2:08 PM
finance.yahoo.com logoWhy Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?
finance.yahoo.com - September 7 at 3:39 PM
marketbeat.com logoCredit Suisse AG Has $1.71 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
marketbeat.com - September 6 at 4:24 AM
marketbeat.com logoExodusPoint Capital Management LP Has $1.04 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
marketbeat.com - September 5 at 5:27 AM
finance.yahoo.com logoWhy Is Intercept (ICPT) Up 0.6% Since Last Earnings Report?
finance.yahoo.com - September 1 at 5:23 PM
marketbeat.com logoLeerink Partnrs Equities Analysts Lift Earnings Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
marketbeat.com - August 28 at 2:18 AM
marketbeat.com logoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Acquired by Pictet Asset Management SA
marketbeat.com - August 23 at 6:10 AM
marketbeat.com logoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Bought by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - August 22 at 4:21 AM
marketbeat.com logoQ3 2023 Earnings Forecast for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Issued By Zacks Research
marketbeat.com - August 21 at 1:52 AM
marketbeat.com logoZacks Research Weighs in on Intercept Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ICPT)
marketbeat.com - August 18 at 8:18 AM
marketbeat.com logoIntercept Pharmaceuticals (NASDAQ:ICPT) Downgraded to Hold at StockNews.com
marketbeat.com - August 11 at 1:10 AM
marketbeat.com logoB. Riley Weighs in on Intercept Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ICPT)
marketbeat.com - August 7 at 8:28 AM
msn.com logoCanaccord Genuity Maintains Intercept Pharmaceuticals (ICPT) Buy Recommendation
msn.com - August 4 at 2:38 AM
seekingalpha.com logoIntercept: Narrowed Market, Concentrated Strategy (Rating Upgrade)
seekingalpha.com - August 3 at 6:45 PM
finanznachrichten.de logoIntercept Pharmaceuticals, Inc.: Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
finanznachrichten.de - August 2 at 1:17 PM
finance.yahoo.com logoIntercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - August 2 at 1:17 PM
finance.yahoo.com logoIntercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Y
finance.yahoo.com - August 2 at 1:16 PM
seekingalpha.com logoIntercept Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 2 at 9:36 AM
marketbeat.com logoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - August 2 at 2:44 AM
marketbeat.com logoArizona State Retirement System Makes New Investment in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
marketbeat.com - August 1 at 6:15 AM
marketbeat.com logoVirtu Financial LLC Buys Shares of 17,609 Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
marketbeat.com - July 27 at 5:24 AM
finance.yahoo.com logoIntercept to Announce Second Quarter 2023 Financial Results on August 2, 2023
finance.yahoo.com - July 26 at 8:11 PM
finance.yahoo.com logoIntercept Pharmaceuticals (ICPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - July 26 at 8:11 PM
msn.com logoHC Wainwright & Co. Upgrades Intercept Pharmaceuticals (ICPT)
msn.com - July 13 at 3:42 PM
Get Intercept Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICPT and its competitors with MarketBeat's FREE daily newsletter.



ICPT Media Mentions By Week

ICPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ICPT
News Sentiment

0.22

0.69

Average
Medical
News Sentiment

ICPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ICPT Articles
This Week

32

4

ICPT Articles
Average Week

Get Intercept Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICPT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ICPT) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -